Infinimmune operates as a biotechnology company.
Infinimmune has raised $12.0M in total funding. The most recent round was Seed. The last funding was announced in December 2022.
Infinimmune's investors include Pear VC, Playground Global, Civilization Ventures, Saya Bio, Axial VC.
Infinimmune is headquartered in San Francisco, United States.
Infinimmune operates as a biotechnology company.
Infinimmune is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Infinimmune — Funding & Investors." VCBacked, December 6, 2022, https://www.vcbacked.co/company/infinimmune. Accessed August 1, 2026.
VCBacked. (2022). Infinimmune — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/infinimmune
{{cite web |title=Infinimmune — Funding & Investors |url=https://www.vcbacked.co/company/infinimmune |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated